In memoriam: John Edmond
John Edmond, an emeritus professor of biological chemistry at the David Geffen School of Medicine at the University of California, Los Angeles, died Feb. 18 at age 85. He had been a member of the ¾«Æ·¹ú²úÒ»Çø¶þÇøÌÒÉ« since 1974.
Edmond was born Jan. 21, 1937, in the village of Fintry, in central Scotland. He went to Glasgow to earn his undergraduate degree and Ph.D. in chemistry, and spent some time as an assistant lecturer at the University of Glasgow. He studied lipids in a basic research lab at Shell Oil in England for several years before being recruited in 1968 to join the biological chemistry department at UCLA.
Edmond remained active in research for more than 30 years, studying developmental neurobiochemistry. He was interested in the need for nutrients to fuel rapid brain growth in newborns; his lab studied neonatal rats and cultured neurons and astrocytes to understand these nutritional demands. Later in his career, he studied the effects of carbon monoxide on the developing brain, demonstrating that even at levels that were then recognized as safe, the gas could permanently damage neurons and cause hearing loss.
"No task was too small to recruit his help," colleagues in his department they wrote about Edmond in March. His commitment to service encompassed years he spent volunteering in many capacities on the university's academic senate, including as chair, along with National Institutes of Health study sections and the editorial board of the Journal of Neuroscience Research.
Edmond is survived by his wife, Lorna; two children; and four grandchildren.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

In memoriam: Michael J. Chamberlin
He discovered RNA polymerase and was an ASBMB member for nearly 60 years.

Building the blueprint to block HIV
Wesley Sundquist will present his work on the HIV capsid and revolutionary drug, Lenacapavir, at the ASBMB Annual Meeting, March 7–10, in Maryland.

In memoriam: Alan G. Goodridge
He made pioneering discoveries on lipid metabolism and was an ASBMB member since 1971.

Alrubaye wins research and teaching awards
He was honored at the NACTA 2025 conference for the Educator Award and at the U of A State and National Awards reception for the Faculty Gold Medal.

Designing life’s building blocks with AI
Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Jordahl named Gilliam Fellow
He will receive three years of funding to support his thesis research.